CARTA CIRCULAR # M1606074 30 de junio de 2016 A TODOS NUESTROS PROVEEDORES PARTICIPANTES Modificador 91 vs 59: Pruebas de Laboratorios repetidas con mismo Diagnóstico Clínico El Current Procedural Terminology CPT®, Edición Profesional, define modificador 91 de la siguiente manera: ''Repeat Clinical Diagnostic Laboratory Test: In the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. Under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. Note: This modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, onetime, reportable result is all that is required. This modifier may not be used when other code (s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). This modifier may only be used for laboratory test (s) performed more than once on the same day on the same patient.'' La codificación con modificadores, publicada por la Asociación American Medical (AMA), dice que el modificador 91 se utiliza para informar la repetición de pruebas clínicas de laboratorio de diagnóstico realizados en el mismo paciente el mismo día. Además, afirman que el modificador 91 no debe utilizarse cuando la segunda prueba o muestra de cultivo es de un sitio diferente. Para este caso el modificador 59 se utiliza en la misma fecha de servicio, a menos que un segundo cultivo (mismo código CPT) se lleva a cabo en el mismo día en el mismo sitio. Los sistemas identifican cuando un modificador 91 ó 59: Se repite el modificador de manera inapropiada con un mismo procedimiento para la misma fecha de servicio. En la revisión de historial de las reclamaciones muestran que no hubo el mismo procedimiento original facturado para esa fecha de servicio sin modificador. Cordialmente, José E. Novoa-Loyola, MD, FACC Principal Oficial Médico CIRCULAR LETTER #M1606074 June 30, 2016 TO ALL OUR PARTICIPANTS PROVIDERS Modifier 91 vs 59: ¨Repeat Clinical Diagnostic Laboratory Test¨ The current CPT® Professional Edition defines modifier 91 as follows: ''Repeat Clinical Diagnostic Laboratory Test: In the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. Under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. Note: This modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, onetime, reportable result is all that is required. This modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). This modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.'' Coding with Modifiers, published by the American Medical Association (AMA), which states ''Modifier 91 is used to report repeat clinical diagnostic laboratory tests performed on the same patient on the same day." In addition, they also state that ''Modifier 91 should not be used when the second test or culture specimen is from a different site; modifier 59 is used on the same date of service unless a second culture (same CPT code) is performed on the same day for the same site.'' The edit system identifies when a: Repeat modifier has been reported inappropriately with a laboratory service or procedure that has not been repeated. Laboratory procedure is submitted with a 59 or 91 modifier, signifying the procedure to be a repeat of the same procedure done previously during the day, yet review of claim history shows that there was no original same procedure submitted for that date of service. Cordially, José E. Novoa-Loyola, MD, FACC Chief Medical Officer